tezacitabine

Known as: 2'-Deoxy-2'-(fluoromethylene)cytidine, Cytidine, 2'-deoxy-2'-(fluoromethylene)-, (2E)-, (E)-2'-deoxy-2'-(fluoromethylene)cytidine 
A synthetic pyrimidine nucleoside analogue with potential antineoplastic activity. Phosphorylated by cellular kinases, tezacitabine is converted into… (More)
National Institutes of Health

Related topics

Related topics

6 relations

Broader (4)

Antineoplastic AgentsDeoxycytidineEnzyme InhibitorsRadiation-Sensitizing Agents

Narrower (1)

MDL 101731
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
A density functional theory study on the kinetics and thermodynamics of N-glycosidic bond cleavage in 5-substituted 2'-deoxycytidines.
B3LYP/6-311+G(2d,p)//B3LYP/6-31+G(d) density functional theory calculations were employed to explore the kinetics and… (More)
Is this relevant?
2007
2007
Detailed exploration of the endothelium: parameterization of flow-mediated dilation through principal component analysis.
Endothelial dysfunction is associated with cardiovascular diseases and their risk factors (CVRF), and flow-mediated dilation (FMD… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2005
2005
Phase I dose-escalation study of tezacitabine in combination with 5-fluorouracil in patients with advanced solid tumors.
BACKGROUND Tezacitabine [(E)-2'-deoxy-2'-(fluoromethylene) cytidine; FMdC] is a novel nucleoside analog with potent… (More)
Is this relevant?
2003
2003
Dose escalation study of tezacitabine in combination with cisplatin in patients with advanced cancer.
BACKGROUND The authors performed a dose escalation study of cisplatin and the novel deoxycytidine analog, tezacitabine, to… (More)
Is this relevant?
Review
2000
Review
2000
Tezacitabine Hoechst Marion Roussel.
Tezacitabine (MDL-101731, KW-2331, FMdC), an antimetabolite deoxycytidine analog, is an irreversible ribonucleotide reductase… (More)
Is this relevant?
1999
1999
Simultaneous determination of deoxyribonucleoside in the presence of ribonucleoside triphosphates in human carcinoma cells by high-performance liquid chromatography.
Simultaneous determination of ribonucleoside and deoxyribonucleoside triphosphates in cells by HPLC is an analytical challenge… (More)
  • table 1
  • figure 1
  • figure 1
Is this relevant?
1999
1999
Potentiation of cytotoxicity and radiosensitization of (E)-2-deoxy-2'-(fluoromethylene) cytidine by pentoxifylline in vitro.
(E)-2'-deoxy-2'-(fluoromethylene) cytidine (FMdC), a novel inhibitor of ribonucleotide-diphosphate reductase, has been shown to… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1997
1997
Antitumor and radiosensitizing effects of (E)-2'-deoxy-2'-(fluoromethylene) cytidine, a novel inhibitor of ribonucleoside diphosphate reductase, on human colon carcinoma xenografts in nude mice.
Antitumor and radiosensitizing effects of (E)-2'-deoxy-2'-(fluromethylene) cytidine (FMdC), a novel inhibitor of ribonucleotide… (More)
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • figure 3
Is this relevant?
1997
1997
An outer-membrane porin inducible by short-chain amides and urea in the methylotrophic bacterium Methylophilus methylotrophus.
The fmdA and fmdB genes encoding formamidase and a putative regulatory protein, respectively, from the methylotrophic bacterium… (More)
  • figure 1
  • figure 3
  • figure 2
  • table 1
Is this relevant?
1994
1994
Regression of human breast tumor xenografts in response to (E)-2'-deoxy-2'-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductase.
(E)-2'-Deoxy-2'-(fluoromethylene)cytidine (MDL 101,731) is a mechanism-based inhibitor of ribonucleoside diphosphate reductase (J… (More)
Is this relevant?